Abstract | AIM: METHODS: Serum samples were collected in 2004-2008 and 2013-2016. The levels of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) were measured by an automated electrochemiluminescence immunoassay using Elecsys sFlt-1 and Elecsys PlGF. After logarithmic transformation, levels of sFlt-1, PlGF and the sFlt-1/PlGF ratio in a woman with AFLP were compared with those in women with HELLP syndrome, using the one-sample t-test. RESULTS: At 37 weeks of gestation, a patient was diagnosed with AFLP based on Swansea criteria (showing six features including elevated transaminases), and she also showed a duodenal ulcer with active bleeding, thrombocytopenia and hypertension. Her serum levels of sFlt-1 and sFlt-1/PlGF ratio were significantly higher than in those with HELLP syndrome (273 040 pg/mL vs 15 135 [mean], P < 0.001; 4236 vs 224, P < 0.001; respectively). However, her serum level of PlGF was not significantly different from those with HELLP syndrome. CONCLUSION: Serum levels of sFlt-1 and the sFlt-1/PlGF ratio, but not PlGF, in a woman with AFLP were markedly higher than those in women with HELLP syndrome. AFLP may be a different clinical entity from HELLP syndrome based on angiogenesis-related factors. Clinically, the sFlt-1/PlGF ratio may be used to rapidly distinguish AFLP from HELLP syndrome.
|
Authors | Hirotada Suzuki, Shiho Nagayama, Chikako Hirashima, Kayo Takahashi, Hironori Takahashi, Manabu Ogoyama, Manabu Nagayama, Koumei Shirasuna, Shigeki Matsubara, Akihide Ohkuchi |
Journal | The journal of obstetrics and gynaecology research
(J Obstet Gynaecol Res)
Vol. 45
Issue 1
Pg. 96-103
(Jan 2019)
ISSN: 1447-0756 [Electronic] Australia |
PMID | 30141235
(Publication Type: Comparative Study, Journal Article)
|
Copyright | © 2018 Japan Society of Obstetrics and Gynecology. |
Chemical References |
- PGF protein, human
- Placenta Growth Factor
- FLT1 protein, human
- Vascular Endothelial Growth Factor Receptor-1
|
Topics |
- Adult
- Fatty Liver
(blood)
- Female
- HELLP Syndrome
(blood)
- Humans
- Placenta Growth Factor
(blood)
- Pregnancy
- Pregnancy Complications
(blood)
- Vascular Endothelial Growth Factor Receptor-1
(blood)
|